China National Pharmaceutical Group (Sinopharm)

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:biotechnology gptkb:state-owned_enterprise
gptkbp:abbreviation	gptkb:Sinopharm
gptkbp:country	gptkb:China
gptkbp:COVID-19_vaccine_developer	yes
gptkbp:founded	1998
gptkbp:hasChineseName	中国医药集团有限公司
gptkbp:headquarters_location	gptkb:Beijing
gptkbp:industry	healthcare pharmaceuticals
gptkbp:keyPerson	gptkb:Liu_Jingzhen
gptkbp:notableProduct	gptkb:Sinopharm_BIBP_COVID-19_vaccine gptkb:Sinopharm_WIBP_COVID-19_vaccine
gptkbp:numberOfEmployees	over 100,000
gptkbp:parentOrganization	gptkb:State-owned_Assets_Supervision_and_Administration_Commission_of_the_State_Council
gptkbp:products	pharmaceuticals medical devices vaccines
gptkbp:revenue	over 500 billion RMB (2022)
gptkbp:servesArea	worldwide
gptkbp:stockExchange	Hong Kong Stock Exchange (for Sinopharm Group)
gptkbp:subsidiary	gptkb:Sinopharm_Group gptkb:China_National_Biotec_Group gptkb:Sinopharm_Group_Co.,_Ltd.
gptkbp:type	gptkb:state-owned_enterprise
gptkbp:UNICEF_COVID-19_vaccine_supplier	yes
gptkbp:website	http://www.sinopharm.com/
gptkbp:WHO_emergency_use_listing	gptkb:Sinopharm_BIBP_COVID-19_vaccine
gptkbp:bfsParent	gptkb:Beijing_Institute_of_Biological_Products
gptkbp:bfsLayer	7
https://www.w3.org/2000/01/rdf-schema#label	China National Pharmaceutical Group (Sinopharm)